ANEB Anebulo Pharmaceuticals, Inc.
Fundamentals / CIK 0001815974 / USDAnebulo Pharmaceuticals, Inc. reported $9.42M in total assets and a net loss of $7.98M through June 30, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANEB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Jun 30, 2025
-
Operating Income FY 2025-$9.10M Operating profit
-
Net Income FY 2025-$7.98M GAAP bottom line
-
Diluted EPS FY 2025-$0.19 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2025$9.04M Total debt: --
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Research & Development | $4.30M | $3.55M | $5.60M | $2.96M | $2.27M |
| Total Operating Expenses | $9.22M | $8.31M | $11.78M | $6.83M | $3.61M |
| Operating Income | -$9.22M | -$8.31M | -$11.78M | -$6.83M | -$3.61M |
| Interest Income | $258K | $249K | $92K | $7.3K | $1.0K |
| Interest Expense | $400K | $200K | -- | -- | $12K |
| Income Before Tax | -- | -- | -- | -- | -$3.61M |
| Net Income | -$8.48M | -$8.20M | -$11.73M | -$6.83M | -$30.25M |
| Basic EPS | -$0.25 | -$0.32 | -$0.47 | $0.29 | -$2.83 |
| Diluted EPS | -$0.25 | -$0.32 | -$0.47 | $0.29 | -$2.83 |
| Basic Shares Outstanding | 33.8M | 25.8M | 25.1M | 23.3M | 13.6M |
| Diluted Shares Outstanding | 33.8M | 25.8M | 25.1M | 23.3M | 13.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.16M | $810K | $1.13M | $638K | $1.22M | $1.31M | $468K | $748K |
| Total Operating Expenses | $2.62M | $2.26M | $2.33M | $1.89M | $2.59M | $2.41M | $1.34M | $1.66M |
| Operating Income | -$2.62M | -$2.26M | -$2.33M | -$1.89M | -$2.59M | -$2.41M | -$1.34M | -$1.66M |
| Interest Income | $85K | $110K | $123K | $102K | $7.1K | $26K | $50K | $68K |
| Interest Expense | $17K | $17K | $300K | $100K | $100K | $100K | -- | $60K |
| Net Income | -$2.00M | -$2.16M | -$2.14M | -$1.68M | -$2.46M | -$2.20M | -$1.35M | -$1.65M |
| Basic EPS | -$0.05 | -$0.05 | -- | -$0.04 | -$0.09 | -$0.08 | -- | -$0.06 |
| Diluted EPS | -$0.05 | -$0.05 | -- | -$0.04 | -$0.09 | -$0.08 | -- | -$0.06 |
| Basic Shares Outstanding | 41.1M | 41.1M | -- | 41.1M | 27.4M | 25.9M | -- | 25.9M |
| Diluted Shares Outstanding | 41.1M | 41.1M | -- | 41.1M | 27.4M | 25.9M | -- | 25.9M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $11.63M | $3.09M | $11.25M | $14.55M | $19.99M | $3.02M |
| Cash & Short-Term Investments | $11.63M | $3.09M | $11.25M | $14.55M | $19.99M | $3.02M |
| Total Current Assets | $11.96M | $3.51M | $11.67M | -- | -- | $3.03M |
| Other Non-Current Assets | $183K | $565K | -- | -- | -- | -- |
| Total Non-Current Assets | $183K | $565K | $0 | -- | -- | $0 |
| Total Assets | $12.15M | $4.07M | $11.67M | $15.58M | $21.65M | $3.03M |
| Accounts Payable | $224K | $156K | $535K | $381K | $110K | -- |
| Total Current Liabilities | -- | -- | -- | -- | -- | $224K |
| Total Non-Current Liabilities | -- | -- | -- | -- | -- | $0 |
| Total Liabilities | $488K | $261K | $1.07M | $513K | $242K | $224K |
| Common Stock | $41K | $26K | $26K | $23K | $23K | $12K |
| Retained Earnings | -$73.89M | -$65.40M | -$57.20M | -$45.47M | -$38.64M | -$183K |
| Total Stockholders' Equity | $11.66M | $3.81M | $10.60M | $15.07M | $21.41M | -$171K |
| Total Equity | $11.66M | $3.81M | $10.60M | $15.07M | $21.41M | -$171K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $9.04M | $10.35M | $11.63M | $13.28M | $15.00M | $1.40M | $3.09M | $5.15M |
| Cash & Short-Term Investments | $9.04M | $10.35M | $11.63M | $13.28M | $15.00M | $1.40M | $3.09M | $5.15M |
| Total Current Assets | $9.27M | $10.54M | $11.96M | $13.81M | $15.40M | $1.96M | $3.51M | $5.37M |
| Other Non-Current Assets | $148K | $166K | $183K | $201K | $446K | $505K | $565K | $625K |
| Total Non-Current Assets | $148K | $166K | $183K | $201K | $446K | $505K | $565K | $625K |
| Total Assets | $9.42M | $10.70M | $12.15M | $14.01M | $15.84M | $2.47M | $4.07M | $6.00M |
| Accounts Payable | $555K | $608K | $224K | $428K | $320K | $252K | $156K | $385K |
| Total Liabilities | $1.49M | $964K | $488K | $546K | $879K | $569K | $261K | $1.01M |
| Common Stock | $41K | $41K | $41K | $41K | $41K | $26K | $26K | $26K |
| Retained Earnings | -$78.05M | -$76.05M | -$73.89M | -$71.74M | -$70.07M | -$67.60M | -$65.40M | -$64.05M |
| Total Stockholders' Equity | $7.94M | $9.74M | $11.66M | $13.46M | $14.96M | $1.90M | $3.81M | $4.99M |
| Total Equity | $7.94M | $9.74M | $11.66M | $13.46M | $14.96M | $1.90M | $3.81M | $4.99M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Net Income | -$8.48M | -$8.20M | -$11.73M | -$6.83M | -$30.25M |
| Stock-Based Compensation | $1.45M | $759K | $885K | $481K | $200K |
| Change in Payables | $68K | -$378K | $154K | $271K | $110K |
| Operating Cash Flow | -$6.35M | -$8.09M | -$9.68M | -$5.44M | -$4.87M |
| Common Stock Issued | $15.00M | -- | $6.65M | -- | $20.60M |
| Financing Cash Flow | $14.88M | -$62K | $6.38M | -- | $21.83M |
| Net Change in Cash | $8.53M | -$8.15M | -$3.30M | -$5.44M | $16.96M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.00M | -$2.16M | -$2.14M | -$1.68M | -$2.46M | -$2.20M | -$1.35M | -$1.65M |
| Stock-Based Compensation | $199K | $238K | $340K | $300K | $564K | $287K | $177K | $200K |
| Change in Payables | -$53K | $383K | -$203K | $146K | $30K | $96K | -$228K | $66K |
| Operating Cash Flow | -$1.31M | -$1.27M | -$1.65M | -$1.60M | -$1.41M | -$1.69M | -$2.05M | -$1.50M |
| Net Change in Cash | -$1.31M | -$1.27M | -$1.65M | -$1.72M | $13.59M | -$1.69M | -$2.05M | -$1.50M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | -72.8% | -215.1% | -110.7% | -45.3% | -141.3% |
| Return on Assets (ROA) | -69.9% | -201.4% | -100.5% | -43.8% | -139.7% |
| EPS Growth (YoY) | -- | -- | -262.1% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -100.5% | -86.7% | -72.8% | -57.1% | -51.2% | -417.2% | -215.1% | -187.5% |
| Return on Assets (ROA) | -84.7% | -78.9% | -69.9% | -54.9% | -48.4% | -321.0% | -201.4% | -155.9% |